Logo image of NBR

NABORS INDUSTRIES LTD (NBR) Stock Fundamental Analysis

NYSE:NBR - New York Stock Exchange, Inc. - BMG6359F1370 - Common Stock - Currency: USD

26.03  -0.59 (-2.22%)

Fundamental Rating

2

Taking everything into account, NBR scores 2 out of 10 in our fundamental rating. NBR was compared to 63 industry peers in the Energy Equipment & Services industry. Both the profitability and financial health of NBR have multiple concerns. NBR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year NBR has reported negative net income.
NBR had a positive operating cash flow in the past year.
In the past 5 years NBR always reported negative net income.
Each year in the past 5 years NBR had a positive operating cash flow.
NBR Yearly Net Income VS EBIT VS OCF VS FCFNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

NBR has a worse Return On Assets (-2.76%) than 73.02% of its industry peers.
Looking at the Return On Equity, with a value of -40.73%, NBR is doing worse than 84.13% of the companies in the same industry.
NBR has a Return On Invested Capital of 3.93%. This is in the lower half of the industry: NBR underperforms 69.84% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NBR is significantly below the industry average of 8.65%.
The 3 year average ROIC (3.54%) for NBR is below the current ROIC(3.93%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.76%
ROE -40.73%
ROIC 3.93%
ROA(3y)-4.38%
ROA(5y)-7.78%
ROE(3y)-88.52%
ROE(5y)-87.38%
ROIC(3y)3.54%
ROIC(5y)N/A
NBR Yearly ROA, ROE, ROICNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

Looking at the Operating Margin, with a value of 7.43%, NBR is doing worse than 61.90% of the companies in the same industry.
The Gross Margin of NBR (40.24%) is better than 79.37% of its industry peers.
NBR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.43%
PM (TTM) N/A
GM 40.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y2.06%
NBR Yearly Profit, Operating, Gross MarginsNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

2

2. Health

2.1 Basic Checks

NBR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for NBR has been increased compared to 1 year ago.
NBR has more shares outstanding than it did 5 years ago.
NBR has a better debt/assets ratio than last year.
NBR Yearly Shares OutstandingNBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
NBR Yearly Total Debt VS Total AssetsNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.33, we must say that NBR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.33, NBR is doing worse than 79.37% of the companies in the same industry.
NBR has a Debt/Equity ratio of 7.84. This is a high value indicating a heavy dependency on external financing.
NBR's Debt to Equity ratio of 7.84 is on the low side compared to the rest of the industry. NBR is outperformed by 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.84
Debt/FCF N/A
Altman-Z 0.33
ROIC/WACC0.57
WACC6.91%
NBR Yearly LT Debt VS Equity VS FCFNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.80 indicates that NBR should not have too much problems paying its short term obligations.
The Current ratio of NBR (1.80) is comparable to the rest of the industry.
NBR has a Quick Ratio of 1.62. This is a normal value and indicates that NBR is financially healthy and should not expect problems in meeting its short term obligations.
NBR's Quick ratio of 1.62 is fine compared to the rest of the industry. NBR outperforms 63.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.62
NBR Yearly Current Assets VS Current LiabilitesNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

NBR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.37%.
NBR shows a decrease in Revenue. In the last year, the revenue decreased by -0.95%.
Measured over the past years, NBR shows a decrease in Revenue. The Revenue has been decreasing by -0.76% on average per year.
EPS 1Y (TTM)6.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%148.02%
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y13.25%
Revenue growth 5Y-0.76%
Sales Q2Q%-0.15%

3.2 Future

The Earnings Per Share is expected to grow by 32.24% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 7.14% on average over the next years.
EPS Next Y76.77%
EPS Next 2Y39.29%
EPS Next 3Y32.24%
EPS Next 5YN/A
Revenue Next Year13.25%
Revenue Next 2Y9.78%
Revenue Next 3Y7.14%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NBR Yearly Revenue VS EstimatesNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
NBR Yearly EPS VS EstimatesNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 -100

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NBR. In the last year negative earnings were reported.
Also next year NBR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NBR Price Earnings VS Forward Price EarningsNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NBR is valued cheaply inside the industry as 87.30% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.16
NBR Per share dataNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

NBR's earnings are expected to grow with 32.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.29%
EPS Next 3Y32.24%

More info and screens

0

5. Dividend

5.1 Amount

NBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NABORS INDUSTRIES LTD

NYSE:NBR (5/28/2025, 1:04:24 PM)

26.03

-0.59 (-2.22%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-21 2025-07-21/amc
Inst Owners88.94%
Inst Owner Change41.41%
Ins Owners6.13%
Ins Owner Change7.14%
Market Cap408.67M
Analysts52
Price Target48.81 (87.51%)
Short Float %9.99%
Short Ratio3.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-73.53%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-58.28%
Min EPS beat(2)-287.9%
Max EPS beat(2)171.33%
EPS beat(4)1
Avg EPS beat(4)-83.09%
Min EPS beat(4)-287.9%
Max EPS beat(4)171.33%
EPS beat(8)1
Avg EPS beat(8)-861.98%
EPS beat(12)3
Avg EPS beat(12)-667.87%
EPS beat(16)3
Avg EPS beat(16)-509.57%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-1.08%
Max Revenue beat(2)2.22%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.71%
Max Revenue beat(4)2.22%
Revenue beat(8)2
Avg Revenue beat(8)-1.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.41%
Revenue beat(16)8
Avg Revenue beat(16)0.02%
PT rev (1m)-19.08%
PT rev (3m)-37.85%
EPS NQ rev (1m)-15.68%
EPS NQ rev (3m)-84.84%
EPS NY rev (1m)-6.24%
EPS NY rev (3m)-16.15%
Revenue NQ rev (1m)1.01%
Revenue NQ rev (3m)1.22%
Revenue NY rev (1m)1.23%
Revenue NY rev (3m)-3.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF 0.73
P/B 1.19
P/tB 1.19
EV/EBITDA 3.16
EPS(TTM)-12.93
EYN/A
EPS(NY)-1.18
Fwd EYN/A
FCF(TTM)-4.22
FCFYN/A
OCF(TTM)35.79
OCFY137.5%
SpS186.79
BVpS21.83
TBVpS21.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.76%
ROE -40.73%
ROCE 4.97%
ROIC 3.93%
ROICexc 4.34%
ROICexgc 4.34%
OM 7.43%
PM (TTM) N/A
GM 40.24%
FCFM N/A
ROA(3y)-4.38%
ROA(5y)-7.78%
ROE(3y)-88.52%
ROE(5y)-87.38%
ROIC(3y)3.54%
ROIC(5y)N/A
ROICexc(3y)4.37%
ROICexc(5y)N/A
ROICexgc(3y)4.37%
ROICexgc(5y)N/A
ROCE(3y)4.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y2.06%
F-Score4
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 7.84
Debt/FCF N/A
Debt/EBITDA 3.17
Cap/Depr 99.66%
Cap/Sales 21.42%
Interest Coverage 250
Cash Conversion 66.24%
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.62
Altman-Z 0.33
F-Score4
WACC6.91%
ROIC/WACC0.57
Cap/Depr(3y)76.54%
Cap/Depr(5y)57.36%
Cap/Sales(3y)17.15%
Cap/Sales(5y)14.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%148.02%
EPS Next Y76.77%
EPS Next 2Y39.29%
EPS Next 3Y32.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y13.25%
Revenue growth 5Y-0.76%
Sales Q2Q%-0.15%
Revenue Next Year13.25%
Revenue Next 2Y9.78%
Revenue Next 3Y7.14%
Revenue Next 5YN/A
EBIT growth 1Y-16.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year277.65%
EBIT Next 3Y65.43%
EBIT Next 5YN/A
FCF growth 1Y-132.19%
FCF growth 3Y-58.66%
FCF growth 5Y-44.51%
OCF growth 1Y-8.45%
OCF growth 3Y10.68%
OCF growth 5Y-3.21%